Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 267

1.

Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.

Correia JB, Patel MM, Nakagomi O, Montenegro FM, Germano EM, Correia NB, Cuevas LE, Parashar UD, Cunliffe NA, Nakagomi T.

J Infect Dis. 2010 Feb 1;201(3):363-9. doi: 10.1086/649843.

2.

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.

Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, Guerra SF, Oliveira AS, da Silva VB, Sanchez N, Meyer N, Shafi F, Ortega-Barria E, Soriano-Gabarró M, Colindres RE.

Pediatr Infect Dis J. 2011 May;30(5):396-401. doi: 10.1097/INF.0b013e3182055cc2.

PMID:
21150692
3.

Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case-control study.

Ichihara MY, Rodrigues LC, Teles Santos CA, Teixeira Mda G, De Jesus SR, Alvim De Matos SM, Gagliardi Leite JP, Barreto ML.

Vaccine. 2014 May 13;32(23):2740-7. doi: 10.1016/j.vaccine.2014.01.007. Epub 2014 Feb 5.

4.

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.

Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD.

Pediatrics. 2010 Feb;125(2):e199-207. doi: 10.1542/peds.2009-1021. Epub 2010 Jan 18.

PMID:
20083525
5.

Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants.

Salinas B, Pérez Schael I, Linhares AC, Ruiz Palacios GM, Guerrero ML, Yarzábal JP, Cervantes Y, Costa Clemens S, Damaso S, Hardt K, De Vos B.

Pediatr Infect Dis J. 2005 Sep;24(9):807-16.

PMID:
16148848
6.

Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study.

Patel MM, Patzi M, Pastor D, Nina A, Roca Y, Alvarez L, Iniguez V, Rivera R, Tam KI, Quaye O, Bowen M, Parashar U, De Oliveira LH.

BMJ. 2013 Jun 19;346:f3726. doi: 10.1136/bmj.f3726.

7.

Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials.

De Vos B, Han HH, Bouckenooghe A, Debrus S, Gillard P, Ward R, Cheuvart B.

Pediatr Infect Dis J. 2009 Apr;28(4):261-6. doi: 10.1097/INF.0b013e3181907177.

PMID:
19289978
8.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
9.

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

Nakagomi T, Cuevas LE, Gurgel RG, Elrokhsi SH, Belkhir YA, Abugalia M, Dove W, Montenegro FM, Correia JB, Nakagomi O, Cunliffe NA, Hart CA.

Arch Virol. 2008;153(3):591-3. doi: 10.1007/s00705-007-0028-z. Epub 2008 Jan 4.

PMID:
18175037
10.

Effectiveness of monovalent and pentavalent rotavirus vaccine.

Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, Vázquez M.

Pediatrics. 2013 Jul;132(1):e25-33. doi: 10.1542/peds.2012-3804. Epub 2013 Jun 17.

11.

Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.

Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, Lopman BA, Parashar UD; New Vaccine Surveillance Network (NVSN).

Clin Infect Dis. 2011 Aug 1;53(3):245-53. doi: 10.1093/cid/cir307. Epub 2011 Jun 23.

12.

Rotavirus-associated infantile diarrhea in Uberaba, Minas Gerais, on the wake of the Brazilian vaccination program.

Domingues AL, Morais AT, Cruz RL, Moreira LP, Gouvêa VS.

J Clin Virol. 2008 Nov;43(3):298-301. doi: 10.1016/j.jcv.2008.07.008. Epub 2008 Sep 4.

PMID:
18775667
13.

Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia.

Snelling TL, Andrews RM, Kirkwood CD, Culvenor S, Carapetis JR.

Clin Infect Dis. 2011 Jan 15;52(2):191-9. doi: 10.1093/cid/ciq101.

14.
15.

Incidence of rotavirus and all-cause diarrhea in northeast Brazil following the introduction of a national vaccination program.

Gurgel RG, Bohland AK, Vieira SC, Oliveira DM, Fontes PB, Barros VF, Ramos MF, Dove W, Nakagomi T, Nakagomi O, Correia JB, Cunliffe N, Cuevas LE.

Gastroenterology. 2009 Dec;137(6):1970-5. doi: 10.1053/j.gastro.2009.07.046. Epub 2009 Jul 24.

PMID:
19632228
16.

Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses.

Matthijnssens J, Zeller M, Heylen E, De Coster S, Vercauteren J, Braeckman T, Van Herck K, Meyer N, Pirçon JY, Soriano-Gabarro M, Azou M, Capiau H, De Koster J, Maernoudt AS, Raes M, Verdonck L, Verghote M, Vergison A, Van Damme P, Van Ranst M; RotaBel study group.

Clin Microbiol Infect. 2014 Oct;20(10):O702-10. doi: 10.1111/1469-0691.12612. Epub 2014 Mar 29.

17.

Anticipating rotavirus vaccines in Brazil: detection and molecular characterization of emerging rotavirus serotypes G8 and G9 among children with diarrhoea in Recife, Brazil.

Montenegro FM, Correia JB, Rodrigues Falbo A, Dove W, Nakagomi T, Nakagomi O, Cuevas LE, Cunliffe NA, Hart CA.

J Med Virol. 2007 Mar;79(3):335-40.

PMID:
17245712
18.

Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study.

Braeckman T, Van Herck K, Meyer N, Pirçon JY, Soriano-Gabarró M, Heylen E, Zeller M, Azou M, Capiau H, De Koster J, Maernoudt AS, Raes M, Verdonck L, Verghote M, Vergison A, Matthijnssens J, Van Ranst M, Van Damme P; RotaBel Study Group.

BMJ. 2012 Aug 8;345:e4752. doi: 10.1136/bmj.e4752.

19.

Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting.

Snelling TL, Schultz R, Graham J, Roseby R, Barnes GL, Andrews RM, Carapetis JR.

Clin Infect Dis. 2009 Aug 1;49(3):428-31. doi: 10.1086/600395.

20.

Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study.

Groome MJ, Page N, Cortese MM, Moyes J, Zar HJ, Kapongo CN, Mulligan C, Diedericks R, Cohen C, Fleming JA, Seheri M, Mphahlele J, Walaza S, Kahn K, Chhagan M, Steele AD, Parashar UD, Zell ER, Madhi SA.

Lancet Infect Dis. 2014 Nov;14(11):1096-104. doi: 10.1016/S1473-3099(14)70940-5. Epub 2014 Oct 7. Erratum in: Lancet Infect Dis. 2014 Nov;14(11):1040.

PMID:
25303843
Items per page

Supplemental Content

Write to the Help Desk